The pharmaceutical industry is increasing its lobbying efforts and campaign contributions in response to key policy issues, particularly Medicare's price negotiation power.

Increased Spending and Preference for Democratic Candidates

Reports indicate that drugmakers have increased their spending compared to the previous year and have shown a preference for Democratic candidates since 2020.

Contributions to Vice President Kamala Harris

Vice President Kamala Harris has received significant contributions from the pharmaceutical manufacturing sector, surpassing former President Donald Trump.

Pharma-related Political Action Committees (PACs)

Pharma-related political action committees (PACs) distribute funds almost evenly between Democrats and Republicans in congressional races. While some executives make individual contributions, the predominant strategy is the PAC model.

Political Contributions by Eli Lilly and Amgen

Eli Lilly has a balanced approach in its political contributions, while Amgen leans more towards Republican candidates.

Foreign Pharmaceutical Companies and PACs

Foreign pharmaceutical companies engage in the political process through PAC funds sourced from eligible U.S. employees. Roche and AstraZeneca have modest PAC presence and favor Republican contributions.

Evolution of Pharmaceutical Industry's Political Contributions

The pharmaceutical industry's political contributions will likely continue to evolve as debates over healthcare policy and drug pricing continue.